What Taconic Biosciences does

Taconic Biosciences is a US-headquartered, privately held supplier of genetically engineered rodent models and preclinical research services, founded in 1949 and operating facilities in Germantown and Hudson, New York, with additional offices in Copenhagen, Denmark, and a France-based subsidiary (TransCure bioServices) acquired in January 2026. The company's portfolio centers on proprietary mouse and rat models — including the CIEA NOG immunodeficient platform, humanized immune system (HIS) variants such as NOG-EXL, NOG-hIL-2/6/15, FcResolv, and the NeoThy engraftment platform — as well as standard strains, diet-induced disease models (DIO B6, MASH B6), and germ-free mice. Custom model generation is delivered through the ExpressMODEL platform using CRISPR/Cas9, ES cell targeting, and random insertion transgenesis, supported by the eTACONIC project management portal.

Taconic generates revenue through per-unit model sales (e.g., $17 for Swiss Webster, $36 for Sprague Dawley, $105 for DIO B6), project-based custom model development, and recurring colony management, breeding, and cryopreservation services. Additional service revenue comes from flow cytometry, genotyping, microbiome, biospecimen collection, and — following the TransCure acquisition — translational pharmacology and preclinical imaging. The go-to-market is direct enterprise sales via scientific account representatives serving three primary segments: pharmaceutical and biopharma companies, academic and university research institutions, and biotech companies. Taconic is recognized as one of three major global preclinical rodent model suppliers alongside Charles River and Jackson Laboratory, and it maintains multi-channel marketing through scientific conferences, the eTACONIC platform, and an academic grant program that includes the Smart Select free-trial offering.

Name

Taconic Biosciences

Legal name

Taconic Biosciences, Inc.

Website

https://taconic.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Taconic Biosciences is a privately held US-based supplier of genetically engineered rodent models and humanized mouse platforms for pharmaceutical, biotech, and academic preclinical research, offering custom model generation, colony management, and translational research services.

Ownership category

akta.pro rank

Product category

Preclinical Research Models

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)

Keywords

• Preclinical rodent models
• Humanized mouse models
• Genetically engineered mice
• Colony management services
• Custom model generation

Headquarters

HQ city

Hudson

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Research Model Sales: Sale of standardized and specialty mouse and rat models including immunodeficient, humanized, and genetically engineered strains. Revenue generated through per-unit pricing of individual animals with varying prices based on strain, age, and genetic background.
2. Custom Model Development Services: ExpressMODEL® program providing custom genetically engineered rodent model generation for researchers requiring specific genetic modifications. Projects scoped and priced based on model complexity and development timeline requirements.
3. Colony Management and Breeding Services: Ongoing colony management, breeding, and production services for researchers requiring continuous supply of specific model strains. Services include colony expansion, cryopreservation, and rederivation.
4. Scientific Consultation Services: Technical and scientific consultation on model selection, experimental design, and study implementation for preclinical research programs. Often bundled with product sales for enterprise customers.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Taconic Biosciences develops, breeds, and sells genetically engineered mouse and rat models along with supporting laboratory and colony management services for biomedical and preclinical drug discovery research. The portfolio includes immunodeficient and humanized mouse models (notably the NOG family), standard inbred and outbred strains, diet-induced disease models, and custom-generated models via the ExpressMODEL® platform, sold primarily to pharmaceutical companies, biotechnology firms, and academic research institutions.

Product overview

Taconic Biosciences is a global leader in genetically engineered rodent models and preclinical research services. The company's portfolio centers on mouse and rat models including genetically engineered models (knockout, knock-in, transgenic), immunodeficient models (NOG mice, humanized immune system mice), standard strains, and diet-induced disease models. Key product lines include the NOG mouse portfolio for immuno-oncology research, humanized mouse platforms (NeoThy, Humanized Liver), and metabolic disease models (DIO B6, Diet Induced MASH). Services encompass custom model generation (via ExpressMODEL CRISPR platform), colony management, flow cytometry, cryopreservation, microbiome solutions, and biospecimen collection. The company operates the eTACONIC customer portal for project tracking. Following the January 2026 acquisition of TransCure bioServices, the portfolio expanded to include translational pharmacology and preclinical imaging services.

Differentiator

Problem solved

Functional benefit

Brands

• eTACONIC® Platform: Customer portal for custom breeding services providing real-time access to colony inventory.
• TransCure bioServices

Products and services

• Genetically Engineered Models (GEMs) Genetically engineered mouse and rat models including knockout, knock-in, transgenic, knockdown, and cryopreserved variants for preclinical research and drug discovery. Targeted at pharmaceutical, biotechnology, and academic research customers.
• CIEA NOG Mouse Super immunodeficient NOG mouse model for oncology and immuno-oncology research, enabling human tissue engraftment for translational studies. Targeted at preclinical researchers studying human cancer and immune system function.
• Humanized Immune System (HIS) Mice Human immune system engrafted mouse models enabling predictive evaluation of immunotherapies and immune-mediated responses. Targeted at immuno-oncology and immunology researchers in pharma and academia.
• NeoThy Human Immune Engraftment Platform Human immune engraftment platform enabling physiologic human immune function in mice through thymic tissue and HSC engraftment, supporting HLA-restricted T cell development for immunology and immuno-oncology research.
• Humanized Liver Mouse Platform Human hepatocyte-engrafted TK-NOG mice platform for liver-focused drug development and in vivo pharmacology services. Targeted at hepatology, infectious disease, and drug metabolism researchers.
• FcResolv NOG Models Fc-engineered NOG mouse models designed for oncology research evaluating Fc-mediated antibody effector functions. Targeted at antibody therapeutic developers.
• huNOG-EXL Model Portfolio Next-generation humanized NOG-EXL mouse models expressing human cytokines (hGM-CSF/hIL-3) for enhanced human hematopoiesis. Targeted at immuno-oncology and hematology researchers.
• Diet-Induced Obese (DIO) B6 Mouse High-fat diet induced obesity mouse model on C57BL/6NTac background for studying obesity, insulin resistance, and metabolic disorders. Priced at $105 per male mouse (7-9 weeks) and $39 per control male. Targeted at metabolic disease and obesity researchers.
• Diet Induced MASH B6 Mouse Off-the-shelf diet-induced Metabolic Dysfunction-Associated Steatohepatitis (MASH) mouse model for preclinical drug discovery research in liver disease.
• C57BL/6 (B6) Mouse Standard inbred mouse strain widely used in preclinical research, genetic engineering, and as a platform for genetically modified models. Targeted at general biomedical researchers.
• Sprague Dawley Rat Outbred rat model widely used in toxicology, neuroscience, and cardiovascular research, valued for rapid growth and robust reproductive performance. Priced at $36.25 per female rat (3-4 weeks). Targeted at toxicology and pharmacology researchers.
• Swiss Webster Mouse Outbred mouse strain used for decades as an all-purpose stock for research, drug safety testing, and as recipient mothers in transgenic labs. Priced at $17.00 per female mouse (3-4 weeks).
• Standard Immunodeficient Models Immunodeficient mouse and rat models for xenograft studies and human tissue engraftment research. Targeted at oncology and transplantation researchers.
• Germ-Free Mice Axenic mouse models free of all microorganisms for gnotobiotic and microbiome research studies. Targeted at microbiome and infectious disease researchers.
• Neurobiology Models Portfolio Mouse models for neuroscience research including Alzheimer's disease models, Parkinson's disease models, neuropsychiatric disorder models, and humanized apoE models for sporadic Alzheimer's. Targeted at CNS researchers.
• Blood-Brain Barrier Transport Platform Humanized receptor-mediated transport (RMT) models for CNS drug delivery evaluation using humanized TfR1 and CD98hc for receptor-mediated transport and brain exposure studies. Targeted at CNS drug developers.
• Oncology & Immuno-Oncology Models Portfolio Comprehensive portfolio of mouse and rat models for cancer research including syngeneic tumor models, spontaneous tumor models, and transgenic HLA models. Targeted at oncology drug discovery researchers.
• IBD Portfolio Mouse models for inflammatory bowel disease research including colitis models for drug development studies. Targeted at gastroenterology and IBD researchers.
• ADMET Portfolio Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) testing services including xenoreceptor, transporter, and cytochrome P450 panel portfolios. Targeted at drug metabolism and safety pharmacology researchers.
• ExpressMODEL® Custom Model Generation Services Rapid custom genetically engineered rodent model generation service using CRISPR/Cas9 gene editing, ES cell targeting, and random insertion transgenesis to produce knockout, knock-in, transgenic, and knockdown mice and rats. Targeted at researchers needing specific genetic modifications on accelerated timelines.
• Colony Management Solutions Expert planning and agile project management services for animal husbandry, breeding, health monitoring, animal conditioning, accelerated backcrossing, and study animal supply. Targeted at researchers requiring continuous supply of specific model strains.
• Flow Cytometry Services Flow cytometry analysis services for immune profiling and cellular characterization in preclinical studies. Targeted at immunology and cell biology researchers.
• Cryopreservation and Cryorecovery Services Embryology services for germplasm preservation including cryopreservation, cryorecovery, rederivation, and rapid expansion. Targeted at researchers requiring long-term preservation or recovery of specific model strains.
• Genotyping and Genetic Analysis Services Genetic analysis and genotyping services for verifying model genetics and genetic monitoring programs. Targeted at researchers requiring confirmation of genetic background of breeding colonies.
• Microbiome Solutions Services for microbiome research including germ-free mouse models and microbiome analysis for preclinical studies. Targeted at microbiome and infectious disease researchers.
• Protein Analysis Solutions Protein analysis services for biomarker identification and validation in preclinical research. Targeted at researchers conducting molecular characterization studies.
• Biospecimen Collection Murine biospecimen collection services providing blood, plasma, serum, liver, adipose tissue and other tissue types with various preservation methods. Targeted at researchers requiring consistent biological samples.
• Phenotypic Data Packages Phenotypic characterization data packages providing detailed physiological and biochemical parameters for specific models. Targeted at researchers requiring reference data on specific strains.
• eTACONIC® Platform Online customer portal for tracking colony management and model generation projects with real-time access to colony inventory. Targeted at customers with active breeding and custom model projects.
• TransCure bioServices Preclinical in vivo research services in Oncology, Inflammation, and Infectious Diseases, providing translational pharmacology, preclinical imaging, and immune profiling capabilities for bi-specific antibodies, CAR-T therapies, and antibody-drug conjugates. Targeted at advanced therapy developers requiring specialized preclinical study services.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• TransCure bioServicescoreStrategic or Co-development Partner · 20 January 2026Acquisition of TransCure bioServices on January 20, 2026 significantly expanded Taconic's capabilities in immune system humanization (HIS) models and translational pharmacology platforms. The acquisition enhanced Taconic's portfolio of patient-derived xenograft (PDX) models and added expertise in specialized humanized mouse models for oncology and immunology research applications. TransCure's European presence also strengthened Taconic's market position in the region.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/Taconic
• YouTubeyoutube.com/channel/UCsja58L6oojM7jYhXAzw2gQ
• Facebookfacebook.com/taconicbiosciences
• LinkedInlinkedin.com/company/taconic

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taconic Biosciences